US Stock MarketDetailed Quotes
INZY Inozyme Pharma
- 4.255
- -0.145-3.30%
Trading Apr 25 13:32 ET
262.84MMarket Cap-3105P/E (TTM)
4.489High4.180Low345.40KVolume4.300Open4.400Pre Close1.48MTurnover1.01%Turnover RatioLossP/E (Static)61.77MShares7.79552wk High1.87P/B145.24MFloat Cap2.68952wk Low--Dividend TTM34.13MShs Float31.650Historical High--Div YieldTTM7.03%Amplitude0.991Historical Low4.272Avg Price1Lot Size
About Inozyme Pharma Company
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.
Company Profile
SymbolINZY
Company NameInozyme Pharma
Listing DateJul 24, 2020
Issue Price16.00
Founded2015
CEODr. Douglas A. Treco, PhD
MarketNASDAQ
Employees59
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address321 Summer Street,Suite 400
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-330-4340
Websitehttp://www.inozyme.com
Company Executives
- Name
- Position
- Salary
- Dr. Douglas A. Treco, PhD
- Chairman of the Board and Chief Executive Officer
- 106.41K
- Sanjay Subramanian
- Chief Financial Officer and Principal Accounting Officer
- 1.25M
- Matthew Winton
- Chief Operations Officer
- --
- Axel Bolte
- Director
- 2.21M
- Edward T. Mathers
- Independent Director
- 73.41K
- Dr. Sarah Bhagat, PhD
- Independent Director
- 71.91K
- Reinaldo M. Diaz
- Independent Director
- 74.41K
- Dr. Robert Hopfner, M.B.A.,PhD
- Independent Director
- 69.41K
- Dr. Martin William Edwards, M.D.
- Independent Director
- 83.91K
- Lynne Sullivan
- Independent Director
- 79.41K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg